misleading statements

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

Pomerantz Law Firm files class action against Enphase Energy over alleged misstatements regarding inventory management and federal solar tax credit impacts. Stock fell 15.15% after weak Q3 guidance.

Schall Law Firm seeks $PSIX investors for class action over alleged false statements on data center business and manufacturing costs. Deadline: May 19, 2026.

Mereo BioPharma faces class action lawsuit alleging misrepresentations regarding failed Phase 3 clinical trials, with lead plaintiff deadline April 6, 2026.

Class action lawsuit filed against $COPT alleging executives misrepresented relacorilant clinical trial strength and FDA approval prospects, harming investors.

$ALIT shareholders have until May 15, 2026 to join securities fraud lawsuit over alleged misstatements. Stock fell 18.3% and 38.2% after guidance misses in August 2025 and February 2026.

Power Solutions International faces securities fraud class action over false data center claims. Stock plunged 48% following margin disclosures; lead plaintiff deadline set for May 19, 2026.

Rosen Law Firm filed securities class action against Concorde International Group ($CIGL) alleging fraudulent promotion schemes and insider share dumping. Affected investors must act before critical deadlines.

Snowflake faces securities fraud suit after 18% stock drop on corrective disclosures regarding consumption patterns and $10B revenue target claims.

Alight Inc. faces securities fraud lawsuit after missing guidance twice, with stock falling 18-38%. Shareholders can claim losses through May 2026.

Class action lawsuit filed against $PSIX alleging false statements about data center market capabilities and understated manufacturing costs between May 2025 and March 2026.

Power Solutions International shareholders file class action lawsuit alleging false statements about data center demand and manufacturing inefficiencies, following significant stock declines.

Portnoy Law Firm files class action against $ENPH over alleged misstatements about inventory management and tax credit impacts. Stock falls 15% post-earnings.

$SNOW faces class action lawsuit over alleged misstatements on product efficiency, Iceberg Tables, and storage pricing. Stock fell 18% when revenue headwinds disclosed.

Class action lawsuit filed against $PLUG alleging false statements on DOE funding and hydrogen facilities between January-November 2025. Investors have until April 3, 2026 to seek lead plaintiff status.

Class action lawsuit filed against Ultragenyx Pharmaceutical alleging false statements about setrusumab efficacy for Osteogenesis Imperfecta treatment based on flawed trial comparisons.

Class action filed against $EOSE alleging materially false statements and non-disclosure of production delays, battery downtime, and quality control failures.

Class action lawsuit filed against Eos Energy Enterprises ($EOSE) alleging executives made false statements about production capacity, battery downtime, and quality issues from November 2025 to February 2026.

Rosen Law Firm urges MREO investors to act before April 6, 2026 deadline in securities class action alleging misleading clinical trial statements.

Picard Medical faces securities fraud lawsuit alleging false statements, social media manipulation, and insider share dumping scheme during September-October 2025 period.